{"nct_id":"NCT06107413","title":"Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-11-12","start_date_type":"ACTUAL","primary_completion_date":"2026-10","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}